Clinical Trial Update: A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence trial is assessing tiotropium bromide inhalation powder in healthy adults under fasting conditions for COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium Bromide Inhalation Powder (tiotropium bromide)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING